Literature DB >> 10881452

Rural economic development vs. tobacco control? Tensions underlying the use of tobacco settlement funds.

W D Austin1, D Altman.   

Abstract

Some public health advocates in tobacco states, having reconsidered the impacts of the federal tobacco price-support program, have negotiated common tobacco regulatory policy stances with tobacco grower representatives. This paper describes the impact of this rapprochement on the state-level negotiations of Master Settlement Agreement funds. It argues that there are indeed two worthy public health goals: tobacco control and the economic viability of tobacco dependent communities (TDCs), but the immediacy of the threat to the latter, the political potency of tobacco growers, and growers' goal of maintaining tobacco as their farms' anchor bring severe risks to the tobacco control portion of Settlement funds. Among three competing philosophies of economic development for TDCs, none are well evaluated, and two potentially create endless demands on Settlement resources. Public health policy advocates are urged to participate in negotiations on TDC economic development and to forcefully advocate for adequate tobacco control resources.

Entities:  

Mesh:

Year:  2000        PMID: 10881452

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  3 in total

1.  Funding of North Carolina tobacco control programs through the Master Settlement Agreement.

Authors:  Alison Snow Jones; W David Austin; Robert H Beach; David G Altman
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

Review 2.  The Master Settlement Agreement and its impact on tobacco use 10 years later: lessons for physicians about health policy making.

Authors:  Walter J Jones; Gerard A Silvestri
Journal:  Chest       Date:  2010-03       Impact factor: 9.410

3.  The changing role of agriculture in tobacco control policymaking: a South Carolina case study.

Authors:  Sarah Sullivan; Stanton Glantz
Journal:  Soc Sci Med       Date:  2010-08-14       Impact factor: 4.634

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.